XFRA
BZ7A
Market cap4.33bUSD
Sep 17, Last price
5.05EUR
1D
0.00%
1Q
3.48%
Name
Bumrungrad Hospital PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider that operates a network of medical facilities in Thailand and globally. Its core offering is a comprehensive medical center equipped with advanced diagnostic, therapeutic, and intensive care capabilities. The company also boasts an extensive array of approximately 56 specialized outpatient clinics and centers, covering a broad spectrum of medical disciplines. These include, but are not limited to, allergy, cardiology, behavioral health, oncology, dental, diabetes, emergency services, eye care, fertility, digestive disease, women's health, men's health, orthopedics, physical therapy, plastic surgery, and sleep medicine. Beyond direct patient care, Bumrungrad engages in various related activities. These encompass managing real estate holdings, conducting clinical research, distributing pharmaceutical and medical goods through dedicated stores, operating a training and development center for healthcare professionals, and providing patient referral services. With its substantial infrastructure, the company maintains 580 hospital beds across its facilities. Founded in 1980, Bumrungrad Hospital Public Company Limited is headquartered in Bangkok, Thailand.
Key people
Non-Executive Chairman of the Board · since 2018
Artirat Charukitpipat
Chief Executive Officer · since 2019
Chanvit Tanphiphat
Non-Executive Vice Chairman of the Board · since 2018
Suvarn Valaisathien
Non-Executive Vice Chairman of the Board · since 2017
Oraphan Buamuang
Hospital Chief Financial Officer · since 2016
Linda Lisahapanya
Managing Director, Executive Director
David Thomas Boucher
Chief Business Transformation Officer
Kenneth Beasley Love
Corporate Chief Financial Officer · since 2014
Shi Wei Siew
Chief Digital Officer
Aniello Sorrentino
Chief Strategist · since 2017
Pantip Chirakarnjanakorn
Company Secretary · since 2017
Bernard Charnwut Chan
Non-Executive Director · since 2017
Chong Toh
Non-Executive Director
Independent Director · since 2012
Aruni Kettratad
Independent Director
Independent Director
Soradis Vinyaratn
Independent Director
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||